These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7065475)

  • 1. Volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%): definition of "Significant" responsiveness in healthy, normal subjects.
    Boggs PB; Bhat KD; Vekovius WA; Debo MS
    Ann Allergy; 1982 Mar; 48(3):137-8. PubMed ID: 7065475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical significance of volume-adjusted maximal mid-expiratory flow (Iso-volume FEF25-75%) in assessing airway responsiveness to inhaled bronchodilator in asthmatics.
    Boggs PB; Bhat KD; Vekovius WA; Debo MS
    Ann Allergy; 1982 Mar; 48(3):139-42. PubMed ID: 7065476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forced expiratory decay in asthmatic preschool children--is it adult type?
    Vilozni D; Hakim F; Livnat G; Bentur L
    Respir Med; 2013 Jul; 107(7):975-80. PubMed ID: 23664671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Volumetric correction of the maximal expiratory flow 25-75% in chronic obstructive bronchopneumopathies].
    Dull WL; Alexander MR; Kasik JE
    Rev Fr Mal Respir; 1982; 10(5):337-44. PubMed ID: 7178638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of asthmatics to methacholine and suggestion.
    Spector S; Luparello TJ; Kopetzky MT; Souhrada J; Kinsman RA
    Am Rev Respir Dis; 1976 Jan; 113(1):43-50. PubMed ID: 1247214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tiotropium on the pulmonary diffusing capacity.
    Gonlugur U
    Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of bronchodilatation in normal subjects: beta agonist versus atropine.
    Hensley MJ; O'Cain CF; McFadden ER; Ingram RH
    J Appl Physiol Respir Environ Exerc Physiol; 1978 Nov; 45(5):778-82. PubMed ID: 730574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The comparison of positive rates and clinical significance of 8 bronchodilator testing parameters sarcoidosis].
    Wang S; Yan Z; Ye Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1995 Dec; 18(6):363-5, 384. PubMed ID: 8762498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary function in symptom-free asthmatics.
    Yaacob I; Mohammad M
    Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Airway responses in healthy and asthmatic subjects following exposure to low ambient air temperature.
    Zuskin E; Schachter EN; Mustajbegović J
    Acta Med Croatica; 1996; 50(2):97-101. PubMed ID: 8688607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilator characteristics of nebulized metaproterenol sulfate, isoetharine, and atropine in chronic asthma.
    Peerless AG; Rachelefsky GS; Mickey MR; Katz RM; Siegel SC
    J Allergy Clin Immunol; 1983 Dec; 72(6):702-8. PubMed ID: 6358329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for comparing the peak intensity and duration of action of aerosolized bronchodilators using bronchoprovocation with methacholine.
    Ahrens RC; Bonham AC; Maxwell GA; Weinberger MM
    Am Rev Respir Dis; 1984 Jun; 129(6):903-6. PubMed ID: 6375489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aerosol bronchodilator therapy: a comparison of the effects of bronkometer with isoetharine, isoproterenol and phenylephrine.
    Kaimal J; Schwartz HJ; Chester EH
    Ann Allergy; 1979 Sep; 43(3):151-4. PubMed ID: 475065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The volumetric response to bronchodilators in stable chronic obstructive pulmonary disease.
    Walker PP; Calverley PM
    COPD; 2008 Jun; 5(3):147-52. PubMed ID: 18568838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differing patterns of pulmonary function response to bronchodilators in asthmatics.
    Leifer KN; Wittig HJ
    Ann Allergy; 1977 Feb; 38(2):91-5. PubMed ID: 402872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing bronchodilator responsiveness in infants using partial expiratory flow-volume curves.
    Sheikh S; Castile R; Hayes J; McCoy K; Eid N
    Pediatr Pulmonol; 2003 Sep; 36(3):196-201. PubMed ID: 12910580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of alpha-adrenergic blockade with phentolamine on airway function in asthma.
    Campbell SC
    Ann Allergy; 1982 Sep; 49(3):135-8. PubMed ID: 6126146
    [No Abstract]   [Full Text] [Related]  

  • 19. Same efficacies of ipratropium and salbutamol in reversing methacholine-induced bronchoconstriction.
    Delpierre S; Guillot C; Badier M
    J Asthma; 2006 Nov; 43(9):679-85. PubMed ID: 17092849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume adjustment of maximal midexpiratory flow. Importance of changes in total lung capacity.
    Cockcroft DW; Berscheid BA
    Chest; 1980 Oct; 78(4):595-600. PubMed ID: 7418483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.